Article info

Original research
Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma

Authors

  • Marta Alonso-Nocelo Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, SpainCancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain PubMed articlesGoogle scholar articles
  • Laura Ruiz-Cañas Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, SpainCancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain PubMed articlesGoogle scholar articles
  • Patricia Sancho Translational Research Unit, Hospital Miguel Servet, Instituto de Investigacion Sanitaria Aragon, Zaragoza, Spain PubMed articlesGoogle scholar articles
  • Kıvanç Görgülü Comprehensive Cancer Center München, Klinikum rechts der Isar der Technischen Universität München, München, Germany PubMed articlesGoogle scholar articles
  • Sonia Alcalá Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, SpainCancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain PubMed articlesGoogle scholar articles
  • Coral Pedrero Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, SpainCancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain PubMed articlesGoogle scholar articles
  • Mireia Vallespinos Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, SpainCancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain PubMed articlesGoogle scholar articles
  • Juan Carlos López-Gil Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, SpainCancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain PubMed articlesGoogle scholar articles
  • Marina Ochando Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, SpainCancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain PubMed articlesGoogle scholar articles
  • Elena García-García Departamento de Anatomía Patológica, Hospital Universitario Fundación Alcorcón, Alcorcón, Spain PubMed articlesGoogle scholar articles
  • Sara Maria David Trabulo Stem Cells and Cancer Group, Molecular Pathology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain PubMed articlesGoogle scholar articles
  • Paola Martinelli Institute for Cancer Research, Comprehensive Cancer Center, Medizinische Universitat Wien, Wien, Austria PubMed articlesGoogle scholar articles
  • Patricia Sánchez-Tomero Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, SpainCancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain PubMed articlesGoogle scholar articles
  • Carmen Sánchez-Palomo Departamento de Anatomía, Histologia y Neurociencia, Universidad Autónoma de Madrid, Madrid, Spain PubMed articlesGoogle scholar articles
  • Patricia Gonzalez-Santamaría Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, SpainCancer and Human Molecular Genetics, Instituto de Investigación Sanitaria IdiPAZ, Madrid, Spain PubMed articlesGoogle scholar articles
  • Lourdes Yuste Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, SpainCancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, SpainCancer and Human Molecular Genetics, Instituto de Investigación Sanitaria IdiPAZ, Madrid, Spain PubMed articlesGoogle scholar articles
  • Sonja Maria Wörmann Ahmed Cancer Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Derya Kabacaoğlu Comprehensive Cancer Center München, Klinikum rechts der Isar der Technischen Universität München, München, Germany PubMed articlesGoogle scholar articles
  • Julie Earl Molecular Epidemiology and Predictive Tumor Markers Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain, Madrid, SpainGastrointestinal Tumours Research Programme, Biomedical Research Network in Cancer (CIBERONC), Madrid, Spain PubMed articlesGoogle scholar articles
  • Alberto Martin Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain PubMed articlesGoogle scholar articles
  • Fernando Salvador Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain PubMed articlesGoogle scholar articles
  • Sandra Valle Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, SpainCancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain PubMed articlesGoogle scholar articles
  • Laura Martin-Hijano Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, SpainCancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain PubMed articlesGoogle scholar articles
  • Alfredo Carrato Molecular Epidemiology and Predictive Tumor Markers Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain, Madrid, SpainGastrointestinal Tumours Research Programme, Biomedical Research Network in Cancer (CIBERONC), Madrid, SpainAlcala University, Madrid, Spain PubMed articlesGoogle scholar articles
  • Mert Erkan University Research Center for Translational Medicine - KUTTAM, Istanbul, Turkey PubMed articlesGoogle scholar articles
  • Laura García-Bermejo Biomarkers and Therapeutic Targets Group, Area 4, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain PubMed articlesGoogle scholar articles
  • Patrick C Hermann Department of Internal Medicine I, Ulm University, Ulm, Germany PubMed articlesGoogle scholar articles
  • Hana Algül Comprehensive Cancer Center München, Klinikum rechts der Isar der Technischen Universität München, München, Germany PubMed articlesGoogle scholar articles
  • Gema Moreno-Bueno Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, SpainCancer and Human Molecular Genetics, Instituto de Investigación Sanitaria IdiPAZ, Madrid, SpainBreast Cancer Research Programme, Biomedical Research Network in Cancer (CIBERONC), Madrid, SpainFundación MD Anderson Internacional, Madrid, Spain PubMed articlesGoogle scholar articles
  • Christopher Heeschen Stem Cells and Cancer Group, Molecular Pathology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, SpainCenter for Single-Cell Omics and Key Laboratory of Oncogenes and Related Genes, Shanghai Jiao Tong University School of Medicine, Shanghai, China PubMed articlesGoogle scholar articles
  • Francisco Portillo Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, SpainBreast Cancer Research Programme, Biomedical Research Network in Cancer (CIBERONC), Madrid, Spain PubMed articlesGoogle scholar articles
  • Amparo Cano Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, SpainCancer and Human Molecular Genetics, Instituto de Investigación Sanitaria IdiPAZ, Madrid, SpainBreast Cancer Research Programme, Biomedical Research Network in Cancer (CIBERONC), Madrid, Spain PubMed articlesGoogle scholar articles
  • Bruno Sainz, Jr Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, SpainCancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, SpainGastrointestinal Tumours Research Programme, Biomedical Research Network in Cancer (CIBERONC), Madrid, Spain PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Bruno Sainz, Jr, Departamento de Bioquímica, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas Alberto Sols, Madrid, Spain; bsainz{at}iib.uam.es
View Full Text

Citation

Alonso-Nocelo M, Ruiz-Cañas L, Sancho P, et al
Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma

Publication history

  • Received July 5, 2021
  • Accepted March 21, 2022
  • First published April 15, 2022.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.